Prediction of human fetal pharmacokinetics using<i>ex vivo</i>human placenta perfusion studies and physiologically based models

Abstract

The integration of ex vivo human placental perfusion parameters in a p-PBPK model should be a promising new approach for predicting human fetal exposure to xenobiotics.